| Financial Year |
March 31 2023 |
| Monetary Funds |
700,712,809.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
12,378,000.00 |
| Accounts Receivable |
284,908,688.46 |
| Advances to Suppliers |
35,595,630.98 |
| Other Receivables |
44,271,084.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,200,246,165.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,246,045.06 |
| Total Current Assets |
4,289,358,423.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
539,156,600.29 |
| Under-construction Projects |
9,610,637.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
181,476,424.39 |
| R&D expenses |
-- |
| Goodwill |
15,864,059.19 |
| Long-Term Deferred and Prepaid Expenses |
7,470,384.91 |
| Deferred Income Tax Assets |
40,173,423.70 |
| Other Non-Current Assets |
10,127,294.47 |
| Sub-Total of Non-Current Assets |
869,944,552.74 |
| Total Assets |
5,159,302,976.55 |
| Short-Term Loans |
1,359,662,505.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
33,382,859.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
46,475,108.50 |
| Taxes Payable |
6,482,167.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
29,061,121.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
300,000,000.00 |
| Other Current Liabilities |
8,354,000.00 |
| Sub-Total of Current Liabilities |
1,803,562,525.84 |
| Long-term Loans |
527,800,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
62,778.12 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
537,013,127.01 |
| Total Liabilities |
2,340,575,652.85 |
| Paid-In Capital(Or Share Stock) |
1,131,985,440.00 |
| Capital Surplus |
249,392,999.03 |
| Surplus Reserve |
233,594,963.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,677,838,952.47 |
| Minority Stockholder's Interest |
4,291,982.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,814,435,340.74 |
| Owner's Equity（Stockholder's Equity） |
2,818,727,323.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,159,302,976.55 |
